Efficacy and Safety of Upadacitinib in Patients with Ankylosing Spondylitis with Intolerance to And/or Lack of Efficacy of Prior Biologic Therapy: A Subgroup Analysis

被引：0
|
作者：
Baraliakos, Xenofon [1 ]
Ganz, Fabiana [2 ]
Kameda, Hideto [3 ]
Walsh, Jessica [4 ]
Jain, Manish [5 ]
D'Silva, Kristin [6 ]
Wung, Peter [6 ]
Bu, Xianwei [6 ]
Stigler, Jayne [6 ]
Van der Heijde, Desiree [6 ]
机构：
[1] Rheumazentrum Ruhrgebiet Herne, Herne, Germany
[2] AbbVie Inc, Luzern, Switzerland
[3] Toho Univ, Tokyo, Japan
[4] Univ Utah, Salt Lake City, UT USA
[5] Great Lakes Clin Trials, Chicago, IL USA
[6] AbbVie Inc, N Chicago, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0414
引用
收藏
页码：825 / 827
页数：3
相关论文
共 50 条
  • [41] Efficacy and Safety of Apremilast, An Oral Phosphodiesterase Inhibitor, in Ankylosing Spondylitis
    Pathan, E.
    Abraham, S. M.
    Van-Rossen, L.
    Withrington, Robin
    Keat, A. C.
    Charles, Peter J.
    Paterson, E.
    Chowdhury, Muslima
    Hastings, L.
    Fox, A.
    McClinton, C.
    Taylor, Peter
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S646 - S646
  • [42] Efficacy and safety of adalimumab in a patient with ankylosing spondylitis on peritoneal dialysis
    Senol Kobak
    Rheumatology International, 2012, 32 : 1785 - 1787
  • [43] Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial
    van der Heijde, Desiree
    Baraliakos, Xenofon
    Sieper, Joachim
    Deodhar, Atul
    Inman, Robert D.
    Kameda, Hideto
    Zeng, Xiaofeng
    Sui, Yunxia
    Bu, Xianwei
    Pangan, Aileen L.
    Wung, Peter
    Song, In-Ho
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (11) : 1515 - 1523
  • [44] A cost efficacy analysis on Anti-TNF therapy in ankylosing spondylitis.
    Singh, G
    Tandon, N
    Bala, M
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S613 - S613
  • [45] Characteristics of Ankylosing Spondylitis Patients with Primary and Secondary Lack of Efficacy to TNF-Inhibitor Treatments
    Alazmi, Mansour
    Sari, Ismail
    Aycarst, Renise
    Haroon, Nigil
    Inman, Robert D.
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [46] Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period
    Braun, Juergen
    Doedhar, Atul
    Dijkmans, Ben
    Geusens, Piet
    Sieper, Joachim
    Williamson, Paul
    Xu, Weichun
    Visvanathan, Sudha
    Baker, Daniel
    Goldstein, Neil
    Van Der Heijde, Desiree
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (09): : 1270 - 1278
  • [47] The Efficacy and Safety of Jitongning Capsule(脊痛宁胶囊) in Patients with Ankylosing Spondylitis
    王炎焱
    路辉
    赵征
    黄烽
    ChineseJournalofIntegrativeMedicine, 2013, 19 (02) : 98 - 103
  • [48] Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
    Poddubnyy, Denis
    Rudwaleit, Martin
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (04) : 655 - 673
  • [49] Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
    Ogdie, Alexis
    Kristensen, Lars E.
    Soriano, Enrique R.
    Akar, Servet
    Sun, Yanhui
    Gruben, David
    Fallon, Lara
    Kinch, Cassandra D.
    Gladman, Dafna D.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (06) : 1649 - 1664
  • [50] EVALUATION OF EFFICACY AND SAFETY OF SECUKINUMAB IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS
    Emery, Paul
    Baeten, Dominique
    Sieper, Joachim
    Braun, Jurgen
    van der Heijde, D.
    McInnes, Iain
    Van Laar, Jaap
    Landewe, R.
    Wordsworth, Bryan P.
    Wollenhaupt, Jurgen
    Kellner, Herbert
    Paramarta, I.
    Bertolino, Arthur
    Wright, Andrew M.
    Hueber, Wolfgang
    RHEUMATOLOGY, 2012, 51 : 21 - 21
12345